(November 2, 2023, 8:49 AM EDT) -- SAN FRANCISCO — A group of states and the District of Columbia, which sued the U.S. Food and Drug Administration seeking to block any changes to the FDA’s approval or mifepristone and subsequent changes to its prescribing practices, tell the Ninth Circuit U.S. Court of Appeals in an appellee brief that a lower court correctly denied a motion filed by a group of anti-abortion states to intervene....